Caroline is Sionna’s Chief Business Officer. She has more than two decades of biopharma experience and has been responsible for driving significant company growth and value creation through executive leadership in corporate and business development.
Most recently Caroline served as Chief Business Officer of Jnana Therapeutics until its sale to Otsuka Pharmaceutical. At Jnana, Caroline led the team responsible for corporate and business development, alliance management, legal contracts, new product planning, and communications. During her tenure, she drove the formation of two significant partnerships and co-led the process resulting in the sale of Jnana to Otsuka Pharmaceutical. She was previously Head of Business Development at Alnylam Pharmaceuticals, where she led a team responsible for all phases of transactions. Caroline also held business development and strategy roles at Amicus Therapeutics and Bain & Company.
Caroline earned a Master of Business Administration from MIT Sloan School of Management and a Bachelor of Science in Economics from Duke University.